Reusken, C.Mou, H.Godeke, G. J.Hoek, L.Meyer, B.Müller, M. A.Haagmans, B.Sousa, R.Shuurman, N.Rottier, P.Osterhaus, A.Drosten, C.Bosch, B. J.Koopmans, M.2016-10-062016-10-062013-04-04Euro Surveill. 2013 Apr 4;18(14):204411560-7917http://hdl.handle.net/10400.18/4034We present a serological assay for the specific detection of IgM and IgG antibodies against the emerging human coronavirus hCoV-EMC and the SARS-CoV based on protein microarray technology. The assay uses the S1 receptor-binding subunit of the spike protein of hCoV-EMC and SARS-CoV as antigens. The assay has been validated extensively using putative cross-reacting sera of patient cohorts exposed to the four common hCoVs and sera from convalescent patients infected with hCoV-EMC or SARS-CoV.engEmerging Human CoronavirusesProtein MicroarraySpecific SerologyInfecções Sistémicas e Zoonosesjournal article10.2807/1560-7917.ES2015.20.4.21023